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Simultaneous lesion and brain 
segmentation in multiple sclerosis 
using deep neural networks
Richard McKinley1*, Rik Wepfer1, Fabian Aschwanden1, Lorenz Grunder1, Raphaela Muri1, 
Christian Rummel1, Rajeev Verma2, Christian Weisstanner3, Mauricio Reyes4, Anke Salmen5, 
Andrew Chan5, Franca Wagner1 & Roland Wiest1
Segmentation of white matter lesions and deep grey matter structures is an important task in 
the quantification of magnetic resonance imaging in multiple sclerosis. In this paper we explore 
segmentation solutions based on convolutional neural networks (CNNs) for providing fast, 
reliable segmentations of lesions and grey-matter structures in multi-modal MR imaging, and the 
performance of these methods when applied to out-of-centre data. We trained two state-of-the-art 
fully convolutional CNN architectures on the 2016 MSSEG training dataset, which was annotated 
by seven independent human raters: a reference implementation of a 3D Unet, and a more recently 
proposed 3D-to-2D architecture (DeepSCAN). We then retrained those methods on a larger dataset 
from a single centre, with and without labels for other brain structures. We quantified changes in 
performance owing to dataset shift, and changes in performance by adding the additional brain-
structure labels. We also compared performance with freely available reference methods. Both fully-
convolutional CNN methods substantially outperform other approaches in the literature when trained 
and evaluated in cross-validation on the MSSEG dataset, showing agreement with human raters in 
the range of human inter-rater variability. Both architectures showed drops in performance when 
trained on single-centre data and tested on the MSSEG dataset. When trained with the addition of 
weak anatomical labels derived from Freesurfer, the performance of the 3D Unet degraded, while the 
performance of the DeepSCAN net improved. Overall, the DeepSCAN network predicting both lesion 
and anatomical labels was the best-performing network examined.
MR-based imaging biomarkers have been integral diagnostic criteria and disease progression markers for mul-
tiple sclerosis for more than 20  years1. Established biomarkers for MS include baseline MRI lesion count and 
temporal evolution of lesion load, as well as the integrity of the blood brain barrier, signatures of axonal dam-
age, and atrophy of cortical and subcortical grey  matter2. These measures of progression are routinely assessed 
by expert human  readers3. Manual volumetric measurements are not, however, part of clinical routine, owing 
to the time and work required to produce an accurate segmentation. There is a considerable variation in lesion 
quantification between expert readers with different backgrounds (e.g. neuroradiologists vs. neuroimmunolo-
gists), and also substantial intra-rater  variation4. Automated methods are by their nature repeatable, and an 
increasing number of publications have investigated machine learning methods to provide lesion quantification. 
Recently, improvements in hardware and software have enabled fast training and application of convolutional 
neural networks (CNNs), leading to a number of deep learning approaches to lesion segmentation. In the 2016 
MSSEG lesion segmentation challenge at MICCAI, for example, CNN-based approaches won both arms of the 
 challenge5–7. Subsequent papers have used the data arising from this challenge as a reference dataset, improving 
on the results  achieved8.
Automated segmentation methods are already in regular use as a tool in imaging  studies9–14. To train an 
in-house lesion segmentation tool requires both high-quality training data, voxel-level annotation by domain 
experts, and skills in statistical or machine-learning. As a result, most studies employ one of a few freely available 
tools: for example, those cited in the previous sentence all employed the Lesion Segmentation Toolkit (LST), 
OPEN
1Support Center for Advanced Neuroimaging, University Institute for Diagnostic and Interventional 
Neuroradiology, Inselspital, Bern University Hospital, Bern, Switzerland. 2Swiss Paraplegic Centre, Nottwil, 
Switzerland. 3Medizinisch Radiologisches Institut, Zurich, Switzerland. 4ARTORG Centre for Biomedical 
Engineering Research, University of Bern, Bern, Switzerland. 5University Clinic for Neurology, Inselspital, Bern 
University Hospital, Bern, Switzerland. *email: richard.mckinley@insel.ch
2
Vol:.(1234567890)
Scientific Reports |         (2021) 11:1087  | https://doi.org/10.1038/s41598-020-79925-4
www.nature.com/scientificreports/
a plugin for  SPM15. This means that transferability is vital: a classifier trained on data from a single or small 
number of centres must be able to operate well on data from centres and scanners not seen during training, since 
researchers are unlikely to have access to large amounts of labelled training data. Often CNN-based methods do 
not exhibit this property: performance is substantially degraded on external data, with retraining on additional 
labelled data being required before good performance is re-established16. Valverde and coworkers (2018) analysed 
the effect of domain adaptation on their proposed CNN-based MS lesion segmentation method, evaluating the 
minimum number of annotated images needed from the new domain. Domain adaptation was progressively more 
effective with increasing training cases, but the models still yielded a remarkably high performance on reduced 
training sets, such as a single training case. Volumetry of deep grey matter structures is also highly relevant in 
MS: a recent study of 1,417 MS patients showed an association between deep grey matter volume loss and clini-
cal progression in  MS17. In that study, segmentation of the grey matter structures was not carried out directly, 
since the tool used (FSL-FIRST) is known to be biased by the presence of white matter lesions. The white matter 
lesions were identified using LST and removed from the imaging using ‘lesion filling’.
In this paper, we study modern deep learning methods performing a simultaneous segmentation of both 
lesions and grey matter structures, trained on a combination of lesion segmentations produced by manual raters, 
and weak labels for the healthy-appearing tissue provided by an existing automated method (Freesurfer). Deep 
learning has already been applied successfully to the segmentation of healthy  brains18,19. Our hypothesis is that 
modern deep learning architectures can simultaneously perform the tasks of lesion and anatomy segmentation, 
and that these methods are robust enough when applied to data outside of the training sample to distribute and 
use in the context of clinical studies.
Methods
Ethics declaration. All patients included in this study gave general consent for data storage and analysis of 
their MRI datasets. Ethical approval for the retrospective analysis of these anonymized datasets, as performed 
in this study, was granted by the local ethical commission (Cantonal Ethical Commission Bern, ’MS segmenta-
tion disease monitoring’, approval number 2016-02035). The need for explicit written consent was waived by the 
Ethical commission, since the study operated exclusively on anonymized retrospective data.
Study design and overview. We studied in this work the performance of CNN-based lesion segmenta-
tion methods on two datasets: a small publicly available dataset, and a larger dataset from our own centre. The 
datasets belonging to the MSSEG challenge conform to the OFSEP guidelines, guaranteeing 3D FLAIR and a 3D 
T1  imaging7,20. Briefly, 15 datasets were obtained from three different centres in France, each using a different 
scanner: the images were annotated by seven trained junior experts, and their segmentations were fused to pro-
vide a single ground truth for training purposes using LOP-STAPLE21. Our internal dataset comprised 122 fully 
anonymized MRI datasets of patients from the Inselspital (Bern Switzerland) which form part of the MS cohort 
of the University of Bern. We split this data into two cohorts: 90 datasets were included in the Insel90 dataset 
(50 used for training and 40 for validation of the classifier), and 32 patients were included in the Insel32 dataset 
(used in this paper for testing the classifier). All datasets stemmed from patients who fulfilled the diagnostic cri-
teria (revised McDonald criteria of 2010/2017) for relapsing-remitting  MS22. Datasets from the Inselspital were 
acquired using a standardised acquisition protocol on a 3T MRI (Siemens Verio, Siemens, Erlangen, Germany). 
See Table 1 for details of the sequences used on each scanner.
Lesion annotation of the Insel90 and Insel32 datasets was conducted by two of the authors (RWe/FA), under 
the supervision of an experienced neuroradiologist with more than 15 years experience in MS (RWi). Manual 
segmentations of the MS lesions were acquired through slice-by-slice analysis of all four sequences. The 3DSlicer 
 platform23 was used to perform the manual lesion segmentation following a standardised  protocol24. Lesions 
were identified if appearing hyper-intense compared to the surrounding normal-appearing WM on T2w and 
FLAIR images, and slightly to severely hypo-intense on T1-weighted images. A final consensus segmentation 
was prepared by (RMu), supervised by an experienced neuroradiologist with more than 10 years of experience 




3D FLAIR 0.74× 0.74× 0.7 mm
3D T1w 0.74× 0.74× 0.85 mm
2D T2w 0.74× 0.74× 0.85 mm
Siemens Aera 1.5T
3D FLAIR 1.03× 1.03× 1.25 mm
3D T1w 1.08× 1.08× 0.9 mm
2D T2w 0.72× 0.72× 4 mm
Siemens Verio 3T
3D FLAIR 0.5× 0.5× 1.1 mm
3D T1w 1× 1× 1 mm
2D T2w 0.69× 0.69× 3 mm
Insel Siemens Verio 3T
3D FLAIR 0.48× 0.48× 1mm
3D T1w 1× 1× 1 mm
2D T2w 0.42× 0.42× 3 mm
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(FW) who had access to the initial segmentations. This multi-reader ’consensus’ segmentation between three 
raters was used for training and validation of the classifier. One of the authors (RWe) also annotated severely T1 
hypo-intense ’black holes’, which were added as a final label.
Silver standard segmentations of the cortical grey matter, cortical white matter, ventricles, cerebellum, thala-
mus, caudate, putamen, pallidum, hippocampus, amygdala, brain stem, ventral diencephalon, choroid plexus, 
corpus callosum and accumbens area were extracted from the segmentation (aseg.mgz) generated by applying 
Freesurfer 5.3 to the MDEFT acquisition. No distinction was made between left and right hemispheres. In addi-
tion to these tissue labels, Freesurfer also generated labels for white matter hypointensities, which encompass not 
only lesions due to MS, but also age-related physiological changes in the periventricular regions (mild ependymal 
loss, subependymal gliosis and widened extracellular space: tissue labelled as white matter hypointensity but not 
labelled by our raters as MS lesion were assigned this label (non-lesion WMH).
The MSSEG datasets were supplied together with brain masks. Brain masks were prepared for the 122 
T1-weighted MRIs in the Insel datasets using FSL-BET with hand-tuned parameters. These brain masks were 
then transferred to the T2 and FLAIR images using rigid registration by FSL-FLIRT. In addition, we trained a 
DeepSCAN  network25 to predict the BET brain-mask from T1, T2 or FLAIR imaging, to allow application of 
our method to new cases without relying on BET. For the purposes of training segmentation algorithms, the 
data for each case (comprising T1, T2 and FLAIR imaging) was skull-stripped, rigidly registered to the FLAIR 
image, and resampled to 1 mm isovoxels.
In common with standard practice, before training the voxel intensities were standardized, by subtracting the 
mean of voxel intensities withing the brain mask, and dividing by the standard deviation of intensities within 
the brain mask. No other pre-processing was applied
3D-to-2D network: DeepSCAN. In a previous papers on brain tumor segmentation, and longitudi-
nal multiple sclerosis and brain segmentation, we proposed the DeepSCAN  architecture25–27. DeepSCAN is a 
’3D-to-2D’ architecture, meaning that the network takes as input a 3D volume, and predicts labels for the central 
2D slice of that volume. The 3D-to-2D structure of DeepSCAN’s layers combines the benefits of a fully 3D net-
work (3D context) and a 2D network (smaller memory footprint of the input, leading to more available memory 
for feature maps)
A DeepSCAN architecture for MS lesion and neuroanatomy segmentation is shown in Fig. 1.  Following26–28, 
the network was trained using a combination of multi-class cross-entropy loss and a label-flip loss for each indi-
vidual tissue class which quantifies label uncertainty. Training of the classifier was performed using the ADAM 
optimiser, with a cosine-annealing learning rate schedule applied over each  epoch29. The batch size was two, 
with each 3*5*192*192 block being randomly sampled in either an axial, coronal or sagittal direction from one 
of the training examples. The model was trained for 100 epochs (where here an epoch was defined to be 2000 
batches): for the first 50 epochs, a cosine-annealing learning rate schedule running from 1e−4 to 1e−7, for epochs 
50–100 a cosine annealing learning rate running from 1e−5 to 1e−9. For regularization we used weight decay 
(1e−3). Since the lesion class is the class of most interest, and is a minority class among voxels, training slices 
were selected so that each batch contained at least ten voxels of lesion tissue.
When applied to a new case, the classifier is applied in the axial, coronal and sagittal direction. Minimal 
test-time augmentation is performed by also segmenting the volumes mirrored in the sagittal direction. An 
ensembling of these six outputs is then performed by averaging raw logit outputs.
Publicly available benchmark methods: nicMSlesions and SPM Lesion Segmentation Tool-
box. Several methods for segmenting multiple sclerosis lesions are available to download as Docker con-
tainers, self contained software, or SPM modules. We compare the results of our algorithm to a CNN-based 
MS lesion segmentation algorithms,  nicMSlesions6, a patch-based CNN method intended for MS lesion seg-
mentation available from Github (https ://githu b.com/sergi valve rde/nicMS lesio ns/). We also applied algorithms 
from the Lesion Segmentation Toolkit (available at https ://www.appli ed-stati stics .de/lst.html), which are widely 
used in neuroimaging studies. The toolkit provides two segmentation algorithms: a lesion prediction algorithm 
(LPA), operating on FLAIR imaging alone, and a lesion growth algorithm (LGA), operating on FLAIR and T1 
imaging. As recommended by the authors of the toolkit, we used our training cases to determine the best initial 
Figure 1.  The DeepSCAN architecture used in this paper for lesion and brain-structure segmentation.
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threshold for the LGA algorithm. LST and nicMSlesions have both been used as benchmark methods in recent 
publications on MS lesion  segmentation30,31.
3D Unet (nnUnet). The above-mentioned benchmark tools for MS lesion segmentation are all based on 
rather outdated methodologies. Results for 3D Unets (the prevailing architecture for 3D medical image seg-
mentation) on the MSSEG dataset as reported by Salehi et. al and Hashemi et al.8,32 suggest that a vanilla Unet 
performs worse, on that dataset, than the winner of the 2016 MSSEG challenge, a 2D  CNN5, which is somewhat 
surprising. The best performing network in that study was a 3D Unet variant which, like the DeepSCAN net-
work, incorporates dense connections. To ensure that our method performs at a high level we want to compare 
with a state-of-the-art 3D trained for comparison a version of 3D Unet: since the precise Unet architectures used 
in Salehi et al and Hashemi et al is not available, we use the Unet as implemented by Isensee et al. in the nnUnet 
 framework33, on the MSSEG datasets, and on the Insel90 dataset. By using the predefined settings of that frame-
work, which have been shown in the Medical Segmentation Decathlon (http://medic aldec athlo n.com) to work 
well on a variety of medical segmentation tasks, we can ensure that performance of the DeepSCAN network is 
being measured versus a strong benchmark.
Experiments. We first trained a DeepSCAN model, 3D Unet (nnUnet), and nicMSlesions on 50 of the 
Insel90 cases, using the 40 remaining cases for validation, with only the consensus lesion label as ground truth. 
To compare the effect of adding additional labels, we then trained the same model architectures (apart from 
nicMSlesions, which is only designed to segment a single label), from scratch, with additional silver standard 
tissue labels as derived from Freesurfer. On the Insel32 dataset, we assessed the performance of the models with 
and without additional silver standard labels. Benchmark metrics for comparison this dataset were provided by 
the freely available tools LST LPA and LST  LGA15.
We then applied the Unet and DeepSCAN and nicMSlesions models, trained on the Insel90 dataset, to the 
training data of the MSSEG dataset without retraining or tuning, to test the effectiveness of these models on 
multi-centre out-of-sample data. To assess the effect of out-of-sample training, we also trained a 3D Unet and 
a DeepSCAN model, in cross-validation, on the MSSEG training data itself (weights for a nicMSlesions model 
trained on the MSSEG dataset are provided in the downloadable version).
Performance metrics. For performance on MS lesion segmentation, we adopted the performance metrics 
of the MSSEG challenge: a segmentation metric (Dice coefficients) and a lesion detection metric (lesionwise 
F1 score). Definitions of the metrics used can be found in the supplementary material. On the Insel32 dataset 
we compared to the consensus segmentation, while on the MSSEG dataset we compared both to the individual 
raters and to the LOP-STAPLE  consensus7,21.
Direct evaluation of segmentation quality for the brain anatomy labels is not feasible, since the work involved 
in producing high quality full-brain annotations is too high: as a proxy we calculated Dice coefficients for selected 
brain structures on both the Insel90 and MSSEG datasets: here our goal is to determine the relative performance 
between these two datasets, and between the two model architectures.
Results
Test set performance on the Insel32 dataset. Performance metrics on the Insel32 dataset (vs the con-
sensus segmentation) are summarised in Table 2, along with inter-rater comparison between the two raters, 
and between the raters and the consensus. An example of output of the methods considered, together with the 
manual ground truth, can be seen in Fig. 2.
We performed Wilcoxon signed-rank tests of the differences between the methods, with a significance level 
of 0.05. All DeepSCAN and nnUnet models trained performed significantly better than LPA, LGA and nicMSle-
sions, according to both Dice coefficient and F1 score. No significant difference was found between the Dice coef-
ficients of DeepSCAN (lesions only), DeepSCAN (lesions and brain structures) and nnUnet (lesions only): these 
three methods were significantly better regarding Dice coefficient than nnUnet (lesions and brain structures). 
Table 2.  Segmentation and lesion detection metrics on the Insel32 dataset, together with inter-rater statistics. 
Methods labelled * were not trained on the Insel90 dataset, and are provided for reference.
Mean dice coefficient Mean lesion F1 score
Rater A vs rater B 54.8 0.42
Rater A vs consensus 62.7 0.57
Rater B vs consensus 60.3 0.55
LST LPA* 31.9 0.21
LST LGA* 42.26 0.25
nicMSlesion 44.24 0.31
nnUnet (lesions only) 56.2 0.48
DeepSCAN (lesions only) 57.29 0.52
nnUnet (lesions and brain structures) 51.99 0.42
DeepSCAN (lesions and brain structures) 60.0 0.57
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Regarding lesion detection (lesion F1 score), DeepSCAN (lesions and brain structures) was significantly better 
than all other methods.
Performance on MSSEG data: cross-validation vs out-of-sample performance on LOP-STAPLE 
consensus. Both the 3D Unet and the DeepSCAN model achieved state-of-the-art performance on the 
MSSEG dataset when trained in cross-validation, against the LOP-STAPLE consensus segmentation, comfort-
ably outperforming the previously reported best model from Hashemi et al.8 (the previous best performance 
reported in the literature) where the best-performing method reached a Dice coefficient of 70.3 using a Densely 
Figure 2.  Example segmentations of a case from the Insel32 dataset, axial view. (A) FLAIR image, plus 
segmentations from (B) manual raters, (C) LPA, (D) LGA, (E) nicMSlesions and (F) nnUnet (all labels) (G) 
DeepSCAN (just lesions) (H) nnUnet (just lesions) (I) DeepSCAN (all labels). Segmentations from LGA, LPA, 
and nnUnet (all labels) show erroneous segmentation of healthy-appearing tissue near the ventricles (cyan 
arrows). nicMSlesions labels healthy cortical grey matter as lesion tissue (cyan arrows) DeepSCAN (all labels) 
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connected Unet with a Dice loss. Indeed, performance of both DeepSCAN and 3D Unet exceeded that of the 
mean individual rater in terms of Dice coefficient. This suggests that both a plain 3D Unet (nnUnet) and Deep-
SCAN are performing at state-of-the-art levels, when trained in cross-validation on the MSSEG dataset. Both 
methods also substantially outperformed the publicly available nicMSlesions tool with default weights, which 
was trained on data including the MSSEG training dataset (and should therefore, if anything, be somewhat 
overfitted to this dataset).
All methods saw degradation of performance when trained on the larger single centre Insel90 dataset and 
tested on the MSSEG dataset, in line with previous studies. Notably, the two fully-convolutional CNN methods 
performed, when trained on out-of-sample data, similarly to the nicMSlesions (patch-based) CNN trained on in-
sample data. The trend observed in the Insel90 dataset, where additional labels improved results for DeepSCAN 
and worsened results for 3D Unet, is present also in the MSSEG dataset.
A summary of performance for the methods tested on the MSSEG dataset, plus a summary of the inter-rater 
performance on this dataset, is shown in Table 3.
Performance on MSSEG data versus individual raters. The mean Dice coefficient between two indi-
vidual raters on the MSSEG dataset ranged between 54 and 90. (The Dice coefficient between raters R4 and R5 
is 90, an outlier result which seems to have resulted from communication between the raters, as between all the 
other raters the Dice coefficient is below 75. For many lesions R4 and R5 provide identical contours. See for 
example fig. 1 of Commowick et al.7, where sub-figures (d) and (e) have identical annotations for many lesions). 
Dice coefficients for the various different versions of nnUnet and DeepSCAN can be seen in Table 4. As can be 
seen, both methods trained in Cross-validation are comfortably within the range of inter-rater Dice coefficients, 
while of the methods trained on the Insel90 dataset, only DeepSCAN (all labels) performs within the inter-rater 
range.
Segmentation of healthy-appearing grey matter structures on the Insel32 and MSSEG data-
set. Box plots of the Dice coefficient for the segmentation (DeepSCAN multi-task) of various grey matter 
structures, when compared with Freesurfer, can be found in Fig. 3. Both models performed quite robustly when 
applied to the Insel32 dataset. However, the nnUnet model can be seen to make substantial errors in the placing 
of structures on the MSSEG (out of sample) dataset, as can be seen in Fig. 4.
Table 3.  Segmentation and lesion detection metrics against the MSSEG LOP-STAPLE consensus.
Training data set Labels Dice coefficient Lesion-wise F1 score
Expert raters (inter-rater) – – 63.1 0.53
Expert raters (mean vs consensus) – – 73.4 0.69
nicMSlesions MSSEG Lesions 58.7 0.40
nnUnet MSSEG Lesions 74.5 0.62
DeepSCAN MSSEG Lesions 75.7 0.59
nicMSlesions Insel90 Lesions 40.8 0.26
nnUnet Insel90 Lesions 61.8 0.47
DeepSCAN Insel90 Lesions 59.7 0.51
nnUnet Insel90 All labels 60.5 0.47
DeepSCAN Insel90 All labels 66.1 0.55
















Unet Insel90 all 
labels
R1 51.9 62.7 62.3 34.6 50.0 51.7 56.0 50.5
R2 54.0 62.3 63.3 36.7 51.0 51.5 61.0 50.7
R3 53.1 67.6 65.2 37.7 56.1 57.9 60.6 55.7
R4 51.8 58.4 60.0 36.0 48.5 48.8 59.0 48.4
R5 53.4 61.3 61.9 36.5 50.0 50.7 60.3 49.9
R6 51.3 66.3 64.7 36.2 57.4 58.0 60.0 56.2
R7 49.9 68.3 64.6 34.4 58.1 60.1 56.9 57.5
Mean 52.2 63.8 63.1 36.0 53.0 54.1 59.11 52.7
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Discussion
We explored the performance of our in-house developed 3D-to-2D (DeepSCAN) CNN architecture on the 
task of MS lesion segmentation, both with and without simultaneous labelling of healthy-appearing structures, 
comparing it to a state-of-the-art implementation of a 3D Unet, and also to existing, publicly available lesion 
segmentation algorithms, some of which are widely used in neurological and other imaging studies. When 
trained and tested in cross-validation on the multi-centre MSSEG dataset, both DeepSCAN and the 3D Unet 
outperformed previously reported state-of-the-art methods on te same dataset. The two algorithms achieved 
better segmentation agreement with the MSSEG LOP-STAPLE consensus than the mean human rater, and also 
broadly agreed with each other on the lesion segmentation (the mean Dice coefficient between the cross-validated 
Unet and DeepSCAN models was 80.5, higher than all but one pair of individual human raters).
When trained on a larger single-centre dataset, both DeepSCAN and 3D Unet outperformed publicly avail-
able lesion segmentation tools on our internal validation set. All three of Unet, DeepSCAN and nicMSlesions 
Figure 3.  Boxplots of Dice coefficients for selected grey matter structures, for classifiers trained on the Insel90 
dataset, and validated on the Insel32 (in sample) and MSSEG (out of sample) datasets.
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showed drops in performance (relative to the MSSEG cross-validated classifiers) on lesion segmentation and 
detection tasks when trained on the single-site dataset. This is consistent with previous  studies16; however, the 
fully-convolutional networks trained on the Insel data-set had out-of-sample performance similar to the top-
performing models in the original MSSEG challenge and at the lower end of inter-rater variability. We would 
like to mention here in addition that it is difficult to disentangle the effects of the shift in data (between different 
scanners) and the shift in the concept of MS lesion between the lesion annotation protocols (for example, care 
was taken in the Insel dataset to avoid labelling enlarged perivascular spaces as lesion tissue, which does not 
seem to be the case in the MSSEG dataset).
Including weak labels for neuroanatomical structures caused a drop in performance for the 3D Unet, but 
a gain in performance for the DeepSCAN network: this change in performance was more pronounced when 
testing on out-of-sample data. As always, when dealing with deep learning models, it is difficult to attribute a 
cause to this effect, but the reduced performance of the Unet on a larger set of labels could perhaps be because 
of the ratio between the number of labels (18) and the feature depth (30) at the highest resolution layers of the 
network. Compared this with a feature depth of 320 at the highest resolution for DeepSCAN. Increasing the 
feature depth of the Unet while still allowing training on a single GPU would require reducing the size of the 
input patch (currently 128 by 128 by 128), which would undoubtedly lead to decreases in performance due to 
reduced context (as is the case for nicMSlesions, which operates with 11 by 11 by 11 patches). A full study of this 
trade-off deserves its own subsequent analysis.
Mean Dice coefficients between the independent expert raters on the MSSEG dataset ranged between 54 and 
90. Meanwhile the agreement between DeepSCAN and the individual MSSEG raters was between 57 and 61 for 
the classifier trained on the Insel90 dataset, and between 58 and 68 for the classifier trained in cross-validation. 
This suggests that automated classification can operate with similar inter-rater variability to human raters, and 
also points towards the limits of using manual segmentations to judge the performance of segmentation algo-
rithms in MS: in spite of using three raters, supervised by two experts, the lesion annotation we used to train 
our 3D Unet and DeepSCAN models contained (like almost all volumetric annotations of 3D imaging datasets) 
errors. We were able to quantify the extent of these errors by retrospectively examining the results of DeepSCAN 
algorithm. Two raters (FW and LG) made a final assessment of each false positive lesion (i.e. labelled by the 
Figure 4.  An axial slice of case 1016SACH from the MSSEG dataset. Top left, FLAIR, top right, fused ’ground 
truth’, bottom left, DeepSCAN segmentation, trained on the Insel90 dataset, bottom right, nnUnet segmentation, 
trained on the same Insel90 dataset. nnUnet model incorrectly labels parts of Caudate nucleus as Thalamus, and 
incorrectly places boundary between Pallidum and Putamen.
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algorithm but not overlapping the ground truth by more than 10%), and each false negative lesion (i.e. labelled 
in the ground truth but not overlapping with the segmentation of the algorithm by more than 10%). The raters 
were shown each potential false positive/negative lesion, blind to whether the lesion segmentation came from 
the manual raters or the algorithm. The goal was to identify what proportion of ’false positive’ lesions were in 
fact missed by all manual raters, and what proportion of ’false negative’ lesions were in fact mislabelled (i.e. were 
normal-appearing grey matter, choroid plexus, or the result of imaging artefacts). Over all 32 test subjects in the 
Insel32 dataset, there were a total of 2701 lesions annotated in the consensus labelling. Of the 2701 lesions in 
the consensus ground truth, the multi-task DeepSCAN classifier failed to find 777. However, 579 out of those 
777 (75%) were judged by a pair of trained neuroradiologists working together as being mislabelled (i.e. were 
normal-appearing grey matter, choroid plexus, or the result imaging artefacts). Of the 2019 lesions annotated 
by DeepSCAN multi-task, 372 did not overlap more than 10% with lesions in the consensus ground truth. 137 
of those lesions (37%) were subsequently judged to be genuine lesions which had been missed by the manual 
raters. These results, plus the remaining gap in performance between the human raters and algorithms on Lesion 
Detection (the F1 score) suggest that future challenges should focus much more on detection measures than 
segmentation performance in terms of Dice.
There are several limitations of the study that we note, which may be improved in subsequent work. Firstly, 
the proposed method is restricted to work on high quality data similar to that acquired in the MSSEG chal-
lenge, with 3D T1 and FLAIR imaging and 2D T2-weighted imaging. In practice these sequences might not all 
be available. However, this combination of sequences is typical of imaging available in university clinics and 
used in clinical studies. This contrasts with other recent approaches which have employed  MP2RAGE30 or 7 
Telsa  imaging34. It would, of course, be ideal to present a method which can perform at a high level on a variety 
of imaging contrasts. A very recent manuscript by Cerri et al.31 proposes a generative model for MS lesion and 
neuroanatomy segmentation which is contrast-adaptive, allowing lesion segmentation from a variety of different 
contrasts. However despite the authors claims that purely supervised models cannot be expected to perform well 
on out-of-sample data out-of-sample data, this much more sophisticated method achieved a Dice coefficient 
of 0.57 (vs DeepSCAN’s 0.59) against the MSSEG raters, despite having been trained on a substantially larger 
dataset than in this study (212 MS cases from a single centre). It would therefore be interesting to investigate the 
ability of purely supervised methods to cope with a variety of modalities at input, simply by data augmentation. 
Second, we note that our method, which uses 3D convolutions, is not designed to handle data with 2D rather 
than 3D resolution: nor is it able to work at a higher resolution than 1 mm isovoxels. This again limits the appli-
cability and performance of the trained model. Third, both the silver-standard Freesurfer-derived labels and the 
manual labels for lesion contained errors, limiting the reliability of the performance metrics. Manual checking 
of the false/true positives allows to compensate for that, but owing to the substantial work involved in manually 
checking each lesion candidate, we were only able to carry out the this analysis for one of the trained algorithms 
(we selected the DeepSCAN (all labels) algorithm as it was the best performing on both the Insel32 and MSSEG 
datasets). Furthermore, since the MSSEG dataset and Insel datasets were annotated by disjoint sets of raters, the 
effects of scanner- and site-variation in imaging are difficult to disentangle from systematic differences in how the 
lesions were annotated. A more useful comparison for the healthy-appearing tissue labels would be between our 
automated tool and expert manual labels (although these, too, will suffer from substantial inter- and intra-rater 
variability): alternatively, as in Cerri et al.31 a comparison could be made to more robust tools, incorporating 
lesion filling. Finally, we only examined cross-sectional performance: in a companion  study26, we demonstrate 
the applicability of the DeepSCAN classifier for detecting changes in lesion loads, making use of the segmentation 
uncertainty, but it would also be of merit to validate longitudinal performance of a range of classifiers.
In conclusion, we have presented evidence that CNN-based tools have the potential to provide segmentations 
of MS lesions with agreement to human raters similar to inter-rater agreement. Depending on the architecture, 
these tools may also segment healthy-appearing brain tissue without losing performance on lesion segmenta-
tion. Such a tool has the potential to improve both the treatment of MS patients and the quality of neuroimaging 
studies.
Segmentation and detection performance metrics
Dice coefficient. The Dice coefficient, also known as the Dice-Sørenson coefficient or Dice Similarity score, 
is a standard measure of segmentation agreement. If X and Y are two sets, the Dice coefficient is defined as
To maintain consistency with other publications, we display the Dice coefficient as a percentage (i.e. a number 
between 0 and 100).
Lesion detection rates. In addition to assessing the quality of voxel-by-voxel detection of lesion tissue, we also 
assess detection at the lesion level. We follow the proposed lesion detection metrics of the MSSEG 2016 chal-
lenge, for reference see Commowick et al.7.
A “lesion” in a given segmentation will be defined as a connected component of the segmentation (with 
18-connectivity kernel) of size 3 mm3 or greater. We use the notation DX(Y) to stand for the detection rate of 
X-lesions in the segmentation Y, meaning the proportion of lesions in X successfully detected by Y. For these 
purposes, a lesion in X is detected by Y if:
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• The lesions which contribute most to the detection of the lesion (those summing up to γ% of the overlap) 
do not lie more than β% outside the lesion.
A lesion can thus fail to be detected either by “undersegmenting” (the lesion is missed, or is detected but the 
corresponding lesions in Y are too small), or by “oversegmenting” (the corresponding lesions in Y are too large). 
We adopt the values α = 10 , β = 70 , γ = 65  from7. The value DX(Y) is then simply the ratio of the number of 
lesions detected to the total number of lesions in X. If X is the “ground truth” and Y is any other segmentation , 
then DX(Y) measures the proportion of true lesions which were correctly segmented, or sensitivity, of the seg-
mentation Y. In this case, DY (X) is the proportion of lesions segmented by Y which are in “true lesions”, i.e. the 
precision or Positive Predictive Value. The F1 score summarizes these two values in one statistic, and is given by 
the harmonic mean of DX(Y) and DY (X):
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